The TAR domain is an RNA secondary structure element within the leader transcript of the human immunodeficiency virus type 1 (HIV-1) virus. TAR RNA forms the binding site for the viral trans-activator protein Tat and cellular co-factors that are involved in induction of the LTR transcriptional promoter. Here, we report that mutations in the single-stranded bulge- and loop-domains of TAR RNA impair the ability of the virus to replicate in T cell lines. Revertant viruses were isolated upon prolonged culturing and analysed through sequencing. The reversion data confirm the importance of both bulge and loop as sequence-specific recognition motifs. We also analysed the replication phenotype of a mutant HIV-1 virus with a substitution in the -19/-3 promoter region. This mutant displayed delayed infection kinetics compared to the wild-type virus, and revertants with increased replication potential could be isolated. Interestingly, all revertants had acquired an additional mutation at position -2. Primer extension analyses revealed that an upstream shift in transcription start site usage was induced by the -19/-3 substitution. This effect was compensated for by the nucleotide substitution near the RNA start site.
BagasraO.,
KhaliliK.,
SeshammaT.,
TaylorJ. P.,
PomerantzR. J.1992; TAR-independent replication of human immunodeficiency virus type 1 in glial cells. Journal of Virology 66:7522–7528
BerkhoutB.,
JeangK.-T.1989; Trans-activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: a quantitative analysis. Journal of Virology 63:5501–5504
BerkhoutB.,
GatignolA.,
RabsonA. B.,
JeangK. T.1990a; TAR-independent activation of the HIV-1 LTR: evidence that TAR requires regions of the promoter. Cell 62:757–767
BerkhoutB.,
GatignolA.,
SilverJ.,
JeangK. T.1990b; Efficient trans-activation by the HIV-2 Tat protein requires a duplicated TAR RNA structure. Nucleic Acids Research 18:1839–1846
DasA. T.,
KokenS. E. C.,
Oude EssinkB. B.,
van WamelJ. L. B.,
BerkhoutB.1994; Human immunodeficiency virus uses tRNAlys, 3 as primer for reverse transcription in HeLa-CD4+ cells. FEBS Letters 341:49–53
DimitrovD. S.,
WilleyR. I.,
SatoH.,
ChangL.-J.,
BlumenthalR.,
MartinM. A.1993; Quantitation of human immunodeficiency virus type 1 infection kinetics. Journal of Virology 67:2182–2190
DingwallC.,
ErnbergI.,
GaitM. J.,
GreenS. M.,
HeaphyS.,
KarnJ.,
LoweA. D.,
SinghM.,
SkinnerM. A.,
ValerioR.1989; Human immunodeficiency virus 1 Tat protein binds transactivation-responsive region (TAR) RNA in vitro. Proceedings of the National Academy of Sciences, USA 86:6925–6929
DuH.,
RoyA. L.,
RoederR. G.1993; Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters. EMBO Journal 12:501–511
FujitaK.,
SilverJ.,
PedenK.1992; Changes in both gp120 and gp41 can account for increased growth potential and expanded host range of human immunodeficiency virus type 1. Journal of Virology 66:4445–4451
GarciaJ. A.,
WuF. K.,
MitsuyasuR.,
GaynorR. B.1987; Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus. EMBO Journal 6:3761–3770
HarrichD.,
GarciaJ.,
MitsuyasuR.,
GaynorR. B.1990; TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes. EMBO Journal 9:4417–4423
HarrichD.,
HsuC.,
RaceE.,
GaynorR. B.1994; Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants. Journal of Virology 68:5899–5910
JeangK.-T.,
BerkhoutB.,
DropulicB.1993; Effects of integration and replication on transcription of the HIV-1 long terminal repeat. Journal of Biological Chemistry 268:24940–24949
JonesK. A.,
LuciwP. A.,
DuchangeN.1988; Structural arrangements of transcription control domains within the 5′-untranslated leader regions of the HIV-1 and HIV-2 promoters. Genes & Development 2:1101–1114
KamineJ.,
SubramanianT.,
ChinnaduraiG.1991; Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Proceedings of the National Academy of Sciences, USA 88:8510–8514
KimJ. Y.,
Gonzalez-ScaranoF.,
ZeichnerS. L.,
AlwineJ. C.1993; Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the –201 to –10 region of the long terminal repeat. Journal of Virology 67:1658–1662
KlaverB.,
BerkhoutB.1994a; Premature strand transfer by the HIV-1 reverse transcriptase during strong-stop DNA synthesis. Nucleic Acids Research 22:137–144
KokenS. E. C.,
van WamelJ. L. B.,
GoudsmitJ.,
BerkhoutB.,
GeelenJ. L. M. C.1992; Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs. Virology 191:968–972
LeonardJ.,
ParrottC.,
Buckler-WhiteA. J.,
TurnerW.,
RossE. K.,
MartinM. A.,
RabsonA. R.1989; The NF-kB binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. Journal of Virology 63:4919–4924
LiY.,
FlanaganP. M.,
TschochnerH.,
KornbergR. D.1994; RNA polymerase II initiation factor interactions and transcription start site selection. Science 263:805–807
NiedermanT. M. J.,
ThielanB. J.,
RatnerL.1989; Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. Proceedings of the National Academy of Sciences, USA 86:1128–1132
PedenK.,
EmermanM.,
MontagnerL.1991; Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1 LAI, HIV-1 MAL, and HIV-1 ELI. Virology 185:661–672
RhimH.,
ParkJ.,
MorrowC. D.1991; Deletions in the tRNAlys primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription. Journal of Virology 65:4555–4564
RossE. K.,
Buckler-WhiteA. J.,
RabsonA. B.,
EnglundG.,
MartinM. A.1991; Contribution of NF-ĸ B and Sp-1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types. Journal of Virology 65:4350–4358
RoyS.,
DellingU.,
ChenC. H.,
RosenC. A.,
SonenbergN.1990; A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. Genes & Development 4:1365–1373
SouthgateC.,
ZappM. L.,
GreenM. R.1990; Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein. Nature 345:640–642
TaylorJ. P.,
PomerantzR.,
BagasraO.,
ChowdhuryM.,
RappaportJ.,
KhaliliK.,
AminiS.1992; TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation. EMBO Journal 11:3395–3403
TaylorJ. P.,
PomerantzR. J.,
RajG. V.,
KashanshiF.,
BradyJ. N.,
AminiS.,
KhaliliK.1994; Central nervous system-derived cells express a ĸ B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat. Journal of Virology 68:3971–3981
WilleyR. L.,
SmithD. H.,
LaskyL. A.,
TheodoreT. S.,
EarlP. L.,
MossB.,
CaponD. J.,
MartinM. A.1988; In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. Journal of Virology 62:139–147
WilleyR. L.,
RossE. K.,
Buckler-WhiteA. J.,
TheodoreT. S.,
MartinM. A.1989; Functional interaction of constant and variable domains of human immunodeficiency virus type 1 gp120. Journal of Virology 63:3595–3600
Zenzie-GregoryB.,
SheridanP.,
JonesK. A.,
SmaleS. T.1993; HIV-1 core promoter lacks a simple initiator element but contains a bipartite activator at the transcriptional start site. Journal of Biological Chemistry 268:15823–15832